Undergoing in-facility physical activity (PA) programmes initiated before the 20th week of gestation helps reduce the risk of developing gestational diabetes mellitus (GDM) among high-risk mothers, according to the results of a meta-analysis.
High-sensitivity cardiac troponin I (hs-cTnI) is a better marker of cardiovascular disease (CVD) risk in elderly adults than hs-cTnT and improves risk stratification in this population, a recent study has found.
Treatment with sodium-glucose cotransporter-2 inhibitors (SGLT2i) results in a lower risk of clinically relevant cardiovascular death, heart failure (HF) hospitalization, and HF symptoms with similar rates of adverse events (AEs), results of a meta-analysis have shown.
Exenatide once weekly provides effective glucose control and weight loss in patients with type 2 diabetes mellitus, and these benefits are sustained through 18 months of treatment, according to real-world data.
Women who are overweight or obese do not necessarily have lower chances of a successful birth following infertility treatments, including intrauterine insemination, relative to women with normal weight, a study has found.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).